Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
BMC Geriatr ; 19(1): 377, 2019 12 27.
Artículo en Inglés | MEDLINE | ID: mdl-31881861

RESUMEN

BACKGROUND: In the context of an aging population, identifying risk factors for Vancomycin-resistant enterococci (VRE), specific to older people, is important. However, if age is a known risk factor for VRE infection, a limited number of studies have focused on older patients. This study aimed to identify potential risk factors for VRE acquisition in a population aged 65 years and older, during a large VRE outbreak that occurred in a teaching hospital in Lyon, France, from December 2013 to July 2014. METHODS: The present retrospective, multi-center, descriptive, and analytical study used part of a previous cohort, and included only a sub-group of patients aged 65 years and older. The analysis of the factors included in the original study was completed with factors more specific to geriatric patients. Inclusion criteria were patients aged 65 years and older, in contact with a VRE index patient. Patients were screened by rectal swabs. Univariate and multivariate logistic regression analyses were performed. RESULTS: A total of 180 VRE contacts were included and 18 patients became carriers. Multivariate analysis showed that risk factors for VRE acquisition in older people included major contact type (RR: 5.31, 95%CI [1.33; 21.19]), number of antibiotics used (RR: 1.36, 95%CI [1.04; 1.76]), a score of McCabe = 2 (RR: 116.39, 95%CI [5.52; 2455.98]), ethylism (RR: 5.50, 95%CI [1.49; 20.25]), and dementia (RR: 7.50, 95%CI [1.89; 29.80]). CONCLUSIONS: This study was able to demonstrate risk factors for VRE acquisition in older people. These risk factors should be taken into account when in the presence of older people in a VRE infected unit.


Asunto(s)
Envejecimiento/efectos de los fármacos , Envejecimiento/fisiología , Brotes de Enfermedades/prevención & control , Enterococos Resistentes a la Vancomicina/efectos de los fármacos , Enterococos Resistentes a la Vancomicina/fisiología , Vancomicina/farmacología , Anciano , Anciano de 80 o más Años , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Estudios de Cohortes , Infección Hospitalaria/epidemiología , Femenino , Francia/epidemiología , Infecciones por Bacterias Grampositivas , Humanos , Masculino , Estudios Retrospectivos , Factores de Riesgo , Vancomicina/uso terapéutico , Resistencia a la Vancomicina/efectos de los fármacos , Resistencia a la Vancomicina/fisiología
2.
Jt Comm J Qual Patient Saf ; 39(7): 298-305, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23888639

RESUMEN

BACKGROUND: Health care associated Clostridium difficile infections are a major cause of morbidity and mortality in hospitals. In the United States, from 2000 through 2009, discharge diagnoses from hospitals in the United States that included C. difficile increased from 139,000 to 336,600, and the yearly national excess hospital cost associated with hospital-onset C. difficile is estimated to be upwards of $1.3 billion. METHODS: A hospitalwide, multidisciplinary approach was undertaken at Rhode Island Hospital (Providence), a tertiary care hospital. The hospital plan entailed six interventions: (1) develop a C. difficile hospital infection control plan based on a risk assessment; (2) monitor hospitalwide morbidity and mortality associated with C. difficile infection; (3) improve sensitivity of C. difficile toxin detection in stool specimens using a polymerase chain reaction-based nucleic acid amplification assay; (4) enhance environmental cleaning of patient rooms and equipment; (5) develop a C. difficile infection treatment plan; and (6) conduct other interventions. The incidence of health care-associated C. difficile infection was assessed from January 2006 through the third quarter of 2012; the number of colectomies and mortality associated with C. difficile infection were determined from January 2005 through the third quarter of 2012. RESULTS: The incidence of health care-associated C. difficile infection decreased from a peak of 12.2/1,000 discharges during the second quarter of 2006 to 3.6/1,000 discharges during the third quarter of 2012. The yearly mortality in patients with health care-associated C. difficile infection was reduced from a peak of 52 in 2006 to 19 in 2011, with 13 such cases in the first three quarters of 2012. CONCLUSIONS: A hospitalwide multidisciplinary approach can reduce health care-associated C. difficile infection morbidity and mortality.


Asunto(s)
Clostridioides difficile , Infecciones por Clostridium/prevención & control , Colectomía/estadística & datos numéricos , Infección Hospitalaria/prevención & control , Mortalidad Hospitalaria , Control de Infecciones/organización & administración , Antibacterianos/uso terapéutico , Infecciones por Clostridium/tratamiento farmacológico , Infecciones por Clostridium/mortalidad , Infecciones por Clostridium/transmisión , Infección Hospitalaria/tratamiento farmacológico , Infección Hospitalaria/mortalidad , Infección Hospitalaria/transmisión , Heces/microbiología , Servicio de Limpieza en Hospital/organización & administración , Humanos , Incidencia , Reacción en Cadena de la Polimerasa , Calidad de la Atención de Salud , Rhode Island , Trastornos Relacionados con Sustancias , Centros de Atención Terciaria
3.
J Forensic Sci ; 60(6): 1637-9, 2015 11.
Artículo en Inglés | MEDLINE | ID: mdl-26263907

RESUMEN

A 33-year-old female collapsed and died suddenly after presenting with acute dyspnea and increasing cough over the preceding several months. Autopsy revealed poorly differentiated linitis plastica adenocarcinoma of the stomach. Microscopic examination of the lungs showed features consistent with pulmonary tumor thrombotic microangiopathy (PTTM). PTTM is a well-described complication in patients with adenocarcinoma. The typical presentation involves acute pulmonary hypertension, right-sided heart failure, and sudden death, often before the adenocarcinoma is discovered. The pathophysiology of PTTM remains elusive; it has been suggested that carcinoma cells may produce substances that influence pulmonary vasculature. Our patient had classic clinical and histologic features of PTTM in addition to prominent extravascular compression by intralymphatic tumor cells. These features undoubtedly caused her precipitous decline and lethal pulmonary hypertension, induced by underlying adenocarcinoma. This case demonstrates that sudden death can occur from pulmonary hypertension induced by metastatic carcinoma with remarkably little prior symptomatology.


Asunto(s)
Adenocarcinoma/patología , Muerte Súbita/etiología , Neoplasias Pulmonares/secundario , Neoplasias Gástricas/patología , Microangiopatías Trombóticas/patología , Adenocarcinoma/secundario , Adulto , Femenino , Humanos , Hipertensión Pulmonar/etiología , Microangiopatías Trombóticas/etiología
4.
Diagn Mol Pathol ; 19(2): 99-104, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20502187

RESUMEN

Coccidioides immitis/Coccidioides posadasii are common causes of pulmonary infection in certain geographic areas, and are highly infectious when working with culture isolates in the laboratory. Rapid techniques to accurately identify this pathogen in tissues may be of benefit for diagnosis and in limiting the exposure of laboratory personnel to this agent. Locked nucleic acids (LNA) are modified nucleotides in which a ribonucleoside is linked between the 2'-oxygen and the 4'-carbon atoms with a methylene unit. LNA oligonucleotides exhibit increased thermal stability and make excellent probes for in situ hybridization (ISH). In this study, ISH utilizing a biotin-labeled LNA probe targeting Coccidioides sp. ribosomal RNA sequences in 6 formalin-fixed, paraffin-embedded pulmonary tissue specimens from 6 patients with culture positive or histologic findings suggestive of Coccidioides sp. infection is described. The cultures of the pulmonary specimens confirmed C. immitis in 3 of 6 patients. The ISH procedure with the LNA probe was positive in all 6 cases, although the number of organisms that were highlighted varied from rare to numerous. ISH with a biotin-labeled DNA probe of the same sequence was positive in 4 of the 6 cases and the signal intensity and number of organisms was much less than that observed with the LNA probe. Negative control tissues containing a variety of different fungal pathogens including Aspergillus sp., Fusarium sp., Blastomyces dermatitidis, Candida sp, Histoplasma capsulatum, and Zygomyces did not hybridize with the LNA and DNA probes. ISH with an LNA oligonucleotide probe targeting Coccidioides sp. ribosomal RNA is useful for rapid ISH. ISH could be rapidly performed when fungal pathogens are observed in tissue but cultures are negative or have not been performed.


Asunto(s)
Coccidioides/aislamiento & purificación , Coccidioidomicosis/diagnóstico , Hibridación in Situ/métodos , Enfermedades Pulmonares Fúngicas/diagnóstico , Pulmón/microbiología , ARN de Hongos/genética , ARN Ribosómico 5.8S/genética , Adulto , Anciano , Coccidioides/genética , Coccidioidomicosis/microbiología , Coccidioidomicosis/patología , Femenino , Fijadores/farmacología , Formaldehído/farmacología , Humanos , Pulmón/patología , Enfermedades Pulmonares Fúngicas/microbiología , Enfermedades Pulmonares Fúngicas/patología , Masculino , Persona de Mediana Edad , Sondas de Oligonucleótidos/genética , Oligonucleótidos/genética , Adhesión en Parafina , Sensibilidad y Especificidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA